Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1244 results about "Active compound" patented technology

Glp-1r agonist preparation and preparation method therefor

A long-acting injection preparation and a preparation method therefor. The preparation contains an active compound such as the compound as shown in formula (I) or formula (II), or compound 6, or a stereoisomer, pharmaceutically acceptable salt or deuterated compound thereof, and at least one pharmaceutically acceptable carrier.
Owner:ASCLETIS PHARMA (CHINA) CO LTD

Phosphoalkyl ribose polymers comprising biologically active compounds

Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, R4, R5, L, L1, L2, L3, L4, M, q, w and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.
Owner:SONY GROUP CORP

Pyrrolobenzodiazepine conjugates for cancer treatment

Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer, or salt thereof, wherein R1, R2, R3, R4, R5, L1a, L1b, L2, L3, L4, L5, L6, L7, M1, M2, q, w, m and n are as defined herein. Compounds of structure (I) find utility in a number of applications, including use as therapeutic agents for various treatment methods.
Owner:SONY GROUP CORP

Automated synthesis of polymeric dual drugs

Compounds useful as biologically active compounds with or without fluorescent or colored dyes are disclosed. In some embodiments, the compounds have the following structure (I): (I) or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, L11, M1, M2, M3, l, m, n, p, and q are as defined herein. Additional compound, methods of preparation, pharmaceutical compositions, and methods of treatment related to compounds of Structure (I) are also provided.
Owner:SONY GROUP CORP

Oil suspending agent containing pleuromutilin and preparation method thereof

The invention belongs to the field of pesticide preparations, and particularly relates to an oil suspending agent containing pleuromutilin and a preparation method of the oil suspending agent. According to the invention, by optimizing the formula, the obtained oil suspending agent can effectively prevent and treat bacterial diseases, the dosage form of the oil suspending agent is more beneficial to application to spraying method pesticide application, and the embodiment verifies that the prevention and treatment effect on the bacterial diseases can reach 90% or above under the condition that the concentration of pleuromutilin is 200PPM. In addition, according to a traditional method, an active compound is obtained through fermentation, and then the active compound is mixed with a corresponding solvent and an auxiliary agent to be processed into a dosage form, so that the cost is high, and great pollution is brought. The method provided by the invention not only meets the control requirements on bacterial diseases, but also saves the energy and power cost from the aspect of process, reduces the use of solvents, is more beneficial to environmental protection, and thus has great economic benefits, environmental benefits and ecological benefits.
Owner:SHAANXI GELIDA BIOTECHNOLOGY CO LTD

Monoclonal antibody that specifically binds to TL1a

PCT designated stage expiredWO2025144089A1AntipyreticAnalgesicsAntigenDisease
The present invention relates to the field of biotechnology and medicine, in particular to a monoclonal antibody or antigen-binding fragment thereof that specifically binds to TNF-like ligand 1A (TL1A). The invention further relates to nucleic acids encoding said antibody, expression vectors, host cells and methods for producing same, methods for producing the antibodies according to the invention, pharmaceutical compositions comprising the antibody or antigen-binding fragment thereof according to the invention, as well as to pharmaceutical compositions comprising the antibody or antigen-binding fragment thereof according to the invention and other therapeutically active compounds; to methods for treating TL1A-mediated diseases or disorders, to use of the antibody or antigen-binding fragment thereof or pharmaceutical composition thereof for treating TL1A-mediated diseases or disorders, and to use of the antibody or antigen-binding fragment thereof according to the invention and other therapeutically active compounds for treating TL1A-mediated diseases or disorders.
Owner:JOINT CO BIOCAD

Redox-active compounds and uses thereof

The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions as well as a redox flow battery comprising said compounds and compositions. Additionally, an assembly for carrying out the inventive method is provided.
Owner:CMBLU ENERGY AG

Programmable dendritic drugs

Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I) or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, L, L1, L2, L3, L4, L5, L6, M, m, and p are as defined herein. Methods associated with preparation and use of such compounds is also provided.
Owner:SONY GROUP CORP

Highly active compounds against COVID-19

The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for the treatment or prevention of the novel 2019 coronavirus disease (COVID-19) in a host, for example a human, in need thereof.
Owner:ATEA PHARMACEUTICALS INC

Ionic polymers comprising biologically active compounds

Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I):or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, L, L1, L2, L3, L4, M and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.
Owner:SONY GROUP CORP

Phosphoalkyl ribose polymers comprising biologically active compounds

Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I):or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, R4, R5, L, L1, L2, L3, L4, M, q, w and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.
Owner:SONY GROUP CORP

Fungicidal mixtures comprising substituted pyridines

The present invention relates to fungicidal mixtures comprising at least one substituted pyridine (compound I) and at least one active compound II in a weight ratio of from 100: 1 to 1: 100; to a method for controlling phytopathogenic harmful fungi using a mixture of at least one compound I and at least one compound II in a weight ratio of 100: 1 to 1: 100; to the use of a mixture comprising compound I and compound II for controlling phytopathogenic harmful fungi; to agrochemical compositions comprising these mixtures; and to agrochemical compositions further comprising seeds.
Owner:BASF SE

Method for identifying lactone odor active compounds in milk

The invention relates to the technical field of substance detection and analysis, in particular to a method for identifying lactone odor active compounds in milk. According to the method for identifying the lactone odor active compounds in the milk, provided by the invention, the pretreatment of the milk sample is performed by combining the thin-film solid-phase microextraction with the sequential stirring rod adsorption method, and the gas chromatography-sniffing-mass spectrometry technology is matched, so that the sniffing detection rate of the lactone odor active compounds in the milk is remarkably increased; the method has the advantages of high efficiency, strong operability, environmental protection and the like, and has important application value in milk lactone odor active compound detection and milk flavor evaluation.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD

Small molecule virtual screening method and system based on graph convolutional neural network

The invention relates to a small molecule virtual screening method and system based on a graph convolutional neural network, and the method comprises the steps: firstly obtaining the data of an active compound and a bait compound of a target spot, carrying out the preprocessing of the obtained data, constructing a graph convolutional neural network model, carrying out the training and evaluation of the model through a preprocessed data set, and obtaining a small molecule virtual screening result. And then scoring the small molecule compound data obtained in the compound database by using the trained graph convolutional neural network model, retaining the small molecule compound with high prediction score, and finally obtaining the known drug molecule data of the target spot. And performing compound similarity search on the small molecule compounds with high prediction scores and known drug molecules to obtain the small molecule compounds with similarity with the known drug molecules. Compared with the prior art, the method has the advantages that virtual screening is utilized, the drug research and development process is accelerated, the experiment cost is reduced, compound similarity search is combined on the basis, the screening accuracy is further improved, and the screening result range is narrowed.
Owner:NANCHANG ZHONGKE MOBILE MEDICAL IMAGING RESEARCH INSTITUTE

Method for producing particles

The invention relates to a method for producing microparticles comprising at least one organic active compound encapsulated by a shell of an organic wall material, the method comprising i. Providing a water-immiscible liquid containing the organic active compound to be encapsulated and at least one first shell-forming compound (SFC1); ii. Emulsifying the water-immiscible liquid obtained in step i. In an aqueous medium to obtain an oil-in-water (o / w) emulsion of the water-immiscible liquid in the aqueous medium; iii. Adding at least one second shell-forming compound (SFC2) to the aqueous medium or to the emulsion obtained in step ii. Prior to or during performing step ii., thereby obtaining an aqueous suspension of the microparticles; wherein the first shell-forming compound (SFC1) or the second shell-forming compound (SFC2) has 1, 2, 3, 4, 5 or 6, in particular 1, 2, 3 or 4, in particular 1, 2 or 3 first reactive groups (RG1) selected from isocyanate groups, isothiocyanate groups, carbonyl halide groups and carboxylic anhydride groups, per molecule, and the other shell-forming compound has 1, 2, 3, 4, 5 or 6, in particular 1, 2, 3 or 4, per molecule, in particular 1, 2 or 3 second reactive groups (RG2) selected from the group consisting of hydroxyl, thiol and primary amino groups, the first shell-forming compound (SFC1) or the second shell-forming compound (SFC2) having only one reactive group and the other shell-forming compound having 1, 2, 3, 4, 5 or 6, in particular 1, 2, 3 or 4, in particular 1, 2 or 3 reactive groups. The invention also relates to microparticles obtainable by this process and to the use thereof.
Owner:BASF SE

Fungicidal mixtures comprising substituted pyridines

The present invention relates to fungicidal mixtures comprising at least one substituted pyridine (compound I) and at least one active compound II in a weight ratio of from 100: 1 to 1: 100; to a method for controlling phytopathogenic harmful fungi using a mixture of at least one compound I and at least one compound II in a weight ratio of 100: 1 to 1: 100; to the use of a mixture comprising compound I and compound II for controlling phytopathogenic harmful fungi; to agrochemical compositions comprising these mixtures; and to agrochemical compositions further comprising seeds.
Owner:BASF SE

Monoclonal antibody specifically binding to BCMA or antigen binding fragment thereof and use thereof

The invention relates to the field of biotechnology and medicine, in particular to a monoclonal antibody specifically bound with BCMA or an antigen binding fragment of the monoclonal antibody. The invention also relates to nucleic acids encoding said antibodies, expression vectors, host cells and methods for producing the same, methods for producing antibodies according to the invention, pharmaceutical compositions comprising antibodies according to the invention, pharmaceutical compositions comprising antibodies according to the invention and other therapeutically active compounds, methods for treating BCMA-mediated diseases or disorders, and methods for treating BCMA-mediated diseases or disorders. The use of said antibodies or pharmaceutical compositions thereof for the treatment of BCMA-mediated diseases or disorders, and the use of said antibodies and other therapeutically active compounds for the treatment of BCMA-mediated diseases or disorders.
Owner:JOINT CO BIOCAD

Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals

Disclosed are novel pharmaceutical, animal feed compositions and methods of treating non-human animals comprising at least one component selected from the extract(s), fraction(s), active compound(s) and phytochemical(s), or mixtures thereof, derived from non-woody plants of the genus Hesperaloe. Animal feed compositions may comprise a basal animal feed and water soluble solids extracted from Hesperaloe and comprising at least one saponin. The water soluble solids may comprise from about 5 to about 30 wt % saponin. The compositions of the present invention can be used for the treatment of non-human animals, such as poultry and more particularly for preventing and treating coccidiosis. An embodiment provides an immunological composition useful for inducing the production of antibodies to an antigen in a non-human animal comprising an antigen, preferably a coccidia, and a saponin composition extracted from Hesperaloe. The saponins extracted from Hesperaloe biomass may comprise 25(27)-dehydrofucreastatin, 5(6),25(27)-disdehydroyuccaloiside C, 5(6)-disdehydroyuccaloiside C, furcreastatin and yuccaloiside C.
Owner:KIMBERLY CLARK WORLDWIDE INC

Drug virtual screening method and system based on adaptation during testing

The invention discloses a virtual drug screening method and system based on adaptation during testing. The method comprises the following steps that a historical data set of protein pocket-small molecule pairing is collected; constructing a double-encoder framework consisting of a protein pocket encoder and a small molecule encoder; performing joint training on the double-encoder architecture based on the historical data set to obtain a small molecule screening model; and obtaining protein pocket data, and screening and sequencing the candidate small molecules corresponding to the protein pocket data based on the small molecule screening model to obtain corresponding active compounds. According to the method, the adaptation technology during testing is introduced into the virtual drug screening task for the first time, structural specificity dynamic adaptation of the model to an unknown sample is achieved on the premise of not depending on a test label, and the generalization performance is remarkably improved.
Owner:FUDAN UNIVERSITY

Rake type vacuum dryer for diflufenican active compound production

The utility model discloses a rake type vacuum drying machine for diflufenican active compound production, which comprises a drying cylinder, a frame is arranged in the drying cylinder, fins are arranged on the inner side of the frame, guide grooves are arranged on two sides of the frame, a blanking cylinder is arranged at the bottom end of the drying cylinder, an auger shaft is arranged in the blanking cylinder, and the auger shaft is connected with the drying cylinder. And a discharging motor for driving the auger shaft to rotate is arranged on the outer side of the discharging barrel. According to the material drying device, the defects in the prior art are overcome, through the arrangement of the packing auger, dried materials can be rapidly guided out and collected in a centralized mode, the material drying efficiency is improved, and the material drying device has high social use value and application prospects.
Owner:CHIZHOU FEIHAODA CHEM

Catalysts having an electron withdrawing group and their use in polyurethane formulations

PCT designated stage expiredWO2025024345A1Polymer sciencePtru catalyst
The present disclosure generally relates to catalysts having an electron withdrawing group for use in a polyurethane formulation. The polyurethane formulation includes the catalyst having an electron withdrawing group, a compound containing an isocyanate functional group, an active hydrogen-containing compound, a halogenated olefin and optionally one or more of an amine catalyst having at least one tertiary amine group, a non-amine catalyst and an additive.
Owner:HUNTSMAN PETROCHEMICAL LLC

Solid lipid nanoparticles for encapsulation and delivery of bioactive compounds and methods of making the same

Solid lipid nanoparticles (SLNs) for delivery of bioactive compounds are disclosed. The SLNs comprise a lipid matrix and surfactant layer encapsulating at least one bioactive compound selected from vitamins, minerals, enzymes, algae-derived bioactives, proteins, peptides, amino acids, antioxidants, small synthetic molecules, plant-derived volatile compounds, or botanical extracts. The SLNs exhibit submicron particle size, low polydispersity, and sufficient surface charge to ensure colloidal stability and efficient delivery. In one embodiment, algae-based bioactives, such as phycocyanin or fucoxanthin, are encapsulated using only natural and sustainable lipids and surfactants to improve bioavailability and support environmentally friendly formulations. The SLNs may be formulated for oral, topical, transdermal, injectable, ophthalmic, mucosal, textile, veterinary, or agricultural administration. Applications include human and animal health, functional foods, skincare, nutrient supplementation, and crop treatment. The disclosed SLNs offer a biocompatible and scalable delivery system that protects sensitive compounds, enables sustained release, and enhances absorption across diverse industries.
Owner:YUBECK INC

Method for extracting polyphenol from persimmon peel and application

The invention provides a method for extracting polyphenol from persimmon peel and application, the method comprises the steps of persimmon peel pretreatment, irradiation treatment, subcritical ethanol extraction and extraction of polyphenol in different forms, and the method belongs to the technical field of natural product extraction methods. According to the method, electron beam irradiation is utilized to treat persimmon peels, high energy in electron beams can bombard components such as cellulose and lignin in cell walls of the persimmon peels, tightly-combined chemical bonds are broken, ethanol in a subcritical extraction technology can permeate into the persimmon peels to extract polyphenol substances, and therefore the extraction efficiency of polyphenol is improved; and the consumption of the solvent in the extraction process can be reduced. Different forms of polyphenols are further extracted on the basis of the persimmon peel polyphenol crude extract, the polyphenol has good antioxidant capacity and alpha-glucosidase inhibitory activity, bioactive compounds in persimmon peel can be efficiently recycled, and future waste utilization and development of natural antioxidants are promoted.
Owner:NORTHWEST A & F UNIV

Pentacyclic active compound and conjugate thereof and use thereof

The present invention relates to a pentacyclic active compound and a conjugate thereof and a use thereof. The compound and the conjugate have excellent tumor cell inhibition activity, stability and in vivo efficacy in animals.
Owner:CHENGDU CONMED BIOSCI CO LTD

5-chloro-5-phenyl-4, 5-dihydroisoxazole-3-carboxylic acid compound as well as preparation method and application thereof

The invention discloses 5-chloro-5-phenyl-4, 5-dihydroisoxazole-3-carboxylic acid and a derivative thereof (formula I): # imgabs0 #, and in the formula I, R is selected from H, C1-C6 alkyl and C3-C8 cycloalkyl, preferably H, methyl, ethyl, propyl, isopropyl, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. When the compound shown in the formula I is used for synthesizing related active compounds, the synthesis route can be greatly shortened, the yield is increased, and the application prospect is wide.
Owner:ZHENGZHOU INST OF CHIRAL DRUGS RES CO LTD

Marine source penicillium as well as fermentation method and application thereof

The invention discloses marine-derived penicillium as well as a fermentation method and application thereof. The marine source penicillium is named as Penicillium sp.DSF059, and the preservation number of the marine source penicillium is CCTCC (China Center For Type Culture Collection) NO: M 20232310. According to the invention, the culture conditions of the strain are optimized, the culture medium and culture conditions with high yield of antibacterial active compounds are selected for fermentation, more target products can be obtained, the operation is simple, the cost is low, and the method is suitable for industrial production. Meanwhile, the marine-derived penicillium sp. DSF059 can provide an excellent strain for the development of new drugs for resisting plant pathogens such as coffee leaf blight, coffee brown spot, grape gray mold, golden cypress brown spot, citrus black rot, phytophthora capsici, hickory leaf blight and coffee black spot as well as four pathogens separated from coffee leaf diseases and staphylococcus aureus; good application prospects are realized on prevention and treatment of phytopathogen and staphylococcus aureus.
Owner:HAINAN TROPICAL OCEAN UNIV

Organic selenium compound and application thereof in preparation of anti-cancer drugs

The invention provides a novel organic selenium compound and a synthesis method thereof, and application of the compound in preparation of drugs for preventing and / or treating cancers. According to the organic selenium compound provided by the invention, the natural active compound and the selenium element are combined, so that the anticancer activities of the natural active compound and the selenium element generate a synergistic effect, the safety and the anticancer effect of the organic selenium compound are improved, and the organic selenium compound has huge potential in the aspects of preventing and treating cancers. # imgabs0 #
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES